HomeAI · summaries
Storia in 2 fonti
Roche bets $1B+ on DualityBio's ADC tech to tackle payload resistance
Genentech taps DualityBio's DUPAC ADC payload platform in a $45M upfront, $1B+ milestone deal to target payload-resistant tumors.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
DualityBio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs Built on DualityBio's DUPAC…
DualityBio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs Built on DualityBio's DUPAC Novel-Payload Platform
- ·
endpoints.news
Roche bets $1B+ on DualityBio's ADC tech to tackle payload resistance
Genentech taps DualityBio's DUPAC ADC payload platform in a $45M upfront, $1B+ milestone deal to target payload-resistant tumors.